Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Christian Queckenberg"'
Autor:
Xia Li, Juliane Iltgen-Breburda, Christian Queckenberg, Malaz Gazzaz, Matthias Schwab, Martin Jübner, Max Taubert, Elke Schaeffeler, Marc S. Stoffel, Daria Kraus, Chih-hsuan Hsin, Fritz Sörgel, Uwe Fuhr, Martina Kinzig, Christina Trueck
Publikováno v:
Clinical Pharmacology & Therapeutics
We quantified the effect of acute ethanol exposure (initial blood concentrations 0.7 g/L) on major drug metabolizing enzymes and p-glycoprotein. Sixteen healthy Caucasians participated in a randomized crossover study with repeated administration of e
Autor:
Christian Queckenberg, Daria Kraus, Ahmed Abbas Suleiman, Paola Di Gion, Uta Kerkweg, Dennis Rokitta, Dorota Tomalik-Scharte, Uwe Fuhr, Sebastian Frechen
Publikováno v:
The Journal of Clinical Pharmacology. 54:1162-1169
Diurnal changes in the activity of drug metabolizing enzymes may contribute to the variability in drug disposition and drug effects. The aim of this study was to quantify the circadian rhythmicity exhibited by hepatic CYP3A. A 10 μg/kg intravenous b
Autor:
Bertil Wachall, Kathleen Gerbeth, Paola Di Gion, Dorota Tomalik-Scharte, Christian Queckenberg, Mona Tawab, Valerie Erlinghagen, Uwe Fuhr
Publikováno v:
Clinical Therapeutics. 33:1831-1841
Dexamethasone is a glucocorticoid used widely worldwide for immunosuppressive treatment, allergies, bronchiolitis, and croup, among others. For children, liquid formulations are especially suitable because, compared with other dosage forms, both exac
Autor:
S. H. G. Van Os, V. Erlinghagen, M. Wargenau, V. Kubeš, V. Novotný, B. C. M. Baken, Uwe Fuhr, Christian Queckenberg, R. Peroutka
Publikováno v:
Cancer Chemotherapy and Pharmacology, 76, 5, pp. 1081-91
Cancer Chemotherapy and Pharmacology, 76, 1081-91
Cancer Chemotherapy and Pharmacology, 76, 1081-91
Item does not contain fulltext PURPOSE: To describe concentration versus time profiles of capecitabine and its metabolites 5'-DFUR, 5'-DFCR and 5-FU, depending on tablet formulation and on frequent and/or relevant genetic polymorphisms of cytidine de
Autor:
Dorota, Tomalik-Scharte, Ahmed Abbas, Suleiman, Sebastian, Frechen, Daria, Kraus, Uta, Kerkweg, Dennis, Rokitta, Paola, Di Gion, Christian, Queckenberg, Uwe, Fuhr
Publikováno v:
Journal of clinical pharmacology. 54(10)
Diurnal changes in the activity of drug metabolizing enzymes may contribute to the variability in drug disposition and drug effects. The aim of this study was to quantify the circadian rhythmicity exhibited by hepatic CYP3A. A 10 μg/kg intravenous b
Autor:
Christian Queckenberg, Oxana Doroshyenko, Bertil Wachall, Dorota Tomalik-Scharte, Jürgen Meins, Uwe Fuhr, Bärbel Bastian, Mona Abdel-Tawab
Publikováno v:
Web of Science
We evaluated the pharmacokinetics and safety of the antimicrobial agent triclosan after dermal application of a 2% triclosan-containing cream to six volunteers. Percutaneous absorption calculated from urinary excretion was 5.9% ± 2.1% of the dose (m
Autor:
Christian Queckenberg, Uwe Fuhr
Publikováno v:
European journal of clinical pharmacology. 65(2)
Body position may influence physiological characteristics, such as perfusion, gastrointestinal function and plasma volume. These characteristics may interact with key factors determining the pharmacokinetics of drugs (dissolution, absorption, distrib
Publikováno v:
Mycoses. 49
Posaconazole is a new antifungal drug used in prophylaxis and therapy of fungal infections in patients with immunodeficiency. In the clinical development, posaconazole exhibits variable oral bioavailability. Hence drug monitoring is recommended. For